Advanced search

Find pages with...
Then narrow your results by...

About 7 search results

Taperloc Hip System (2019-09-19)

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71351r-eng.php

Oct 25, 2019 ... received an FDA warning letter earlier this year. Zimmer Biomet recently completed an assessment of that supplier following awareness of the warning letter. The assessment focused on devices processed prior to upgrades to the cleaning process, which began in March 2018. The assessment identified that the clinical history of devices processed within that timeframe

Percutaneous Radiofrequency Ablation Catheter and the Potential Risk of Atrioesophageal Fistula

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/66492a-eng.php

Aug 10, 2018 ... of the rare but serious risk of atrioesophageal fistula (AEF) associated with percutaneous radiofrequency (RF) ablation catheters that are used for the treatment of atrial fibrillation (AF). AEF usually occurs within 1 to 6 weeks following an AF ablation procedure using these catheters. While rare, AEF is associated with high morbidity and mortality. Early symptoms

Update on use of "Simply Thick" for infants

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/15074a-eng.php

Jan 29, 2013 ... its advisory to indicate that infants of any age using this product may face increased risk of NEC. The Public Health Agency of Canada, in partnership with the Canadian Paediatric Surveillance Program, undertook a survey of physicians in Canada following Health Canada's 2011 advisory. Two cases of NEC in infants following the use of Simply Thick were reported

Search results

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/simple?js_en=&page=1000&per_page=13000&plain_text=&s=

Mar 30, 2012 ... of plastic For more information, consumers and industry can call one of the following numbers:Nestlé Canada Inc at 1-866-891-0561;CFIA at 1-800-442-2342 / TTY 1-800-465-7735 (8:00 a.m. to 8:00 p.m. Eastern time, Monday to Friday). For more information, consumers and industry can call one of the following... Posted: 2013-03-22 Type of communication: Recall Undeclared

Easton Axis Arrows

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/34241r-eng.php

... recall with Health Canada, the United States Consumer Product Safety Commission (US CPSC) and Easton Technical Products. Affected products Easton Axis Arrows Product description This recall involves Easton Axis arrows in the following four different sizes and batch numbers: Easton Axis Arrows affected by this recall Size Batch Number 300 13169686 340 13170143 400

282 MEP (meprobamate-containing medicine) - Market Withdrawal, Effective October 28, 2013 - For Health Professionals

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/35311a-eng.php

... MEP® is indicated for the relief of pain of various origins, accompanied by muscle spasm and anxiety. Each 282 MEP® tablet contains as medicinal ingredients acetylsalicylic acid (350 mg), codeine phosphate (15 mg), meprobamate (200 mg), and caffeine (15 mg, equivalent to 30 mg caffeine citrate). Following the review of safety and efficacy information for 282

282 MEP (meprobamate-containing medicine) - Market Withdrawal, Effective October 28, 2013 - For the Public

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/35313a-eng.php

... and 282 MEP® will be unavailable after October 28th, 2013. Following the withdrawal of 282 MEP®, no medications containing meprobamate will be available in Canada. PENDOPHARM has also sent a letter to Canadian health care professionals informing them of this safety information. Patients should not stop taking 282 MEP® without speaking to their doctor or pharmacist

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: